Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bittium Corporation: SHARE REPURCHASE 26.5.2023

Bittium Corporation  ANNOUNCEMENT  26.5.2023 Bittium Corporation: SHARE REPURCHASE 26.5.2023 In the Helsinki Stock Exchange Trade date           26.5.2023Bourse trade         BuyShare                  BITTIAmount             4 200 SharesAverage price/ share    4,1379 EURTotal cost            17 379,18 EUR Bittium Corporation now holds a total of 22 291 sharesincluding the shares repurchased on 26.5.2023 On behalf of Bittium Corporation Nordea Bank Oyj

#23-177 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Bulletin from the annual general meeting in Truecaller AB on 26 May 2023

Today, on 26 May 2023, the annual general meeting was held in Truecaller AB. A summary of the adopted resolutions follows below.The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Resolution on adoption of accounts and distribution of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The annual general meeting also resolved to allocate the company’

Fiven ASA - First Quarter Results 2023

· The Q1 2023 Total revenues reached EUR 40.5m representing a reduction of -19.4% versus Q1 2022. · The adjusted EBITDA was EUR 13.0m, versus EUR 11.9m in Q1 2022 (+9,2%) · The EBITDA performance was driven by sustainable growth of the customized products in fast growing end markets in combination with cost reduction effects · Cash Flow from Operations reached EUR 2.8m compared with EUR -0.9m Q1 Last Year · The cash balance ended at EUR 18.6m, down from EUR 18.9m year end 2022 · The March 31 leverage ratio stood at 1.01 Fiven's strategy of developing customized products to

Oral proceedings in the Administrative Court concluded and verdict will be announced on 21 June 2023, at 1 pm.

The Administrative Court in Stockholm (the "Administrative Court") held oral hearings on 25 and 26 May 2023 regarding Humana Assistans AB's ("Humana Assistans") appeal against IVO's decision to revoke Humana Assistans's permit to conduct operations in, among other, personal assistance. The Administrative Court subsequently announced that a verdict will be announced on 21 June 2023 at 1 pm.On 31 January 2023, Humana announced that IVO had decided to revoke Humana Assistans' permit to conduct operations. On February 2, 2023, Humana announced that Humana Assistans had appealed the decision to

Norse Atlantic Airways celebrates inaugural flights from London to Florida

·This week, Norse Atlantic Airways successfully launched two inaugural flights from London Gatwick to Orlando and Fort Lauderdale on May 25th and May 26th respectively  ·These two popular holiday destinations now join Norse Atlantic’s daily New York services from LondonNorse Atlantic Airways celebrated two inaugurals this week with the launch of flights to Orlando and Fort Lauderdale from London Gatwick. The flights, which took off on May 25th and 26th respectively, mark the beginning of a new era of travellers seeking affordable and convenient options to popular holiday

Panoro Energy: Grant of Share Options

Mandatory notification of Trades Oslo, 26 May 2023 - Following the approval by the Ordinary General Meeting ("2023 AGM") of Panoro Energy ASA ("Panoro" or the "Company" with OSE Ticker: PEN) held on 24 May 2023, the Company announces an award of 24,000 options ("Board Options") granted to the Ms Gunvor Ellingsen which will vest equally over a three-year period each at the date of the Annual General Meetings of upcoming years. Each Board Option entitles the holder to one ordinary share in the Company. Once vested, the options are exercisable at NOK 27.40 per share. The exercise price, as

AIEN 2023 award nominations

One of the highlights of the AIEN’s annual International Energy Summit is the AIEN award ceremony, which this year will take place at the Intercontinental Miami, Florida on Wednesday May 31. The awards celebrate impactful industry achievements, underpinned by international energy negotiations and transactions that promote and embody the principles of the AIEN in the energy industry. This year, AIEN has recognized achievements in five categories: Deal of the Year, Venture of the Year, Discovery of the Year, Energy Transition Initiative of the Year and CSR Campaign of the Year. We wish

Pricer’s Chairman of the board will not stand for re-election

Pricer’s Chairman of the board Knut Faremo has informed the nomination committee that he will not stand for re-election at Pricer’s annual general meeting on June 7, 2023. The nomination committee will return shortly with a revised proposal.Knut Faremo has been a member of the board since 2019 and chairman of the board since 2020. “I want to thank Pricer’s shareholders for their trust during these years. Pricer has fantastic possibilities and prospects ahead. However, due to several other commitments, I am unable to devote to this assignment the dedication required and will therefore not

ADDvise announces that the conditions for the early redemption of existing bonds 2021/2024 have been fulfilled

ADDvise Group AB (publ) (the “Company”) announced on 12 May 2023 that it will redeem in full all of its outstanding bonds 2021/2024 with ISIN SE0015222088 (the “Bonds” and “Early Redemption”).The Early Redemption was conditional upon the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023 (the “New Bond Issue”). The issue date for the New Bond Issue occurred today and the conditions for the Early Redemption have therefore been fulfilled. The Early Redemption is therefore no longer conditional and will consequently occur on 9 June 2023. The

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors

Bioretec Ltd  Company announcement 26 May 2023 at 4.30 p.m. EESTThe Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland.   The Annual General Meeting approved the financial statements for the financial year 1 January–31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability for the financial period 1 January–31 December 2022.   The Annual General Meeting resolved in accordance with the proposal of the Board of Directors that the loss of EUR 2,347,332.35 for the financial period 1 January–31 December

Mandatory notification of trade

Didier Breton, Chairman of the Board in Nordhealth AS (the "Company"), has on 26 May 2023 bought 100,000 A shares in the Company at a price of NOK 23 per share. Following the transaction, Didier Breton holds a total of 200,000 A shares in the Company. Please see attached notification forms in accordance with the Market Abuse Regulation article 19. For further information, please contact: Mari Orttenvuori, CFO mari.orttenvuori@nordhealth.com (charles.macbain@nordhealth.com) +358 46 8765 233

BioStock: Prominent role for CombiGene in newly established national ATMP collaboration

The CEO of gene therapy company CombiGene, Jan Nilsson, has been appointed Chairman of CCRM Nordic, Centre for Commercialization of Regenerative Medicine. This national industrial cluster also includes companies such as AstraZeneca, Cytiva, Getinge, Takara Bio Europe, TATAA Biocenter and Verigraft with support from Vinnova, GoCo Health Innovation City and GU Ventures. The goal is to accelerate the investment in advanced medicinaltherapies and contribute to making Sweden a world leader in this field by 2030.Read the article at biostock.se: https://www.biostock.se/en/2023/05/prominent-role-

Update on investment in newcastlemax newbuildings with long-term charters

Reference is made to the stock exchange release dated December 6, 2022, where Ocean Yield AS (“Ocean Yield”) announced an agreement to acquire a minimum of five and a maximum of ten vessels with expected delivery dates between Q1 2025 and Q2 2026. Ocean Yield has now agreed with the charterer that the final transaction scope will be eight or nine vessels, with expected delivery dates between Q3 2024 and Q4 2025. Upon delivery, the vessels will commence 15 year bareboat charters to guaranteed subsidiaries of CMB N.V.

Publication of a Prospectus - 2

Regulatory Announcement Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Authority and, along with the documents incorporated by reference therein, is available for viewing: 4[th] Supplementary Prospectus dated May 26, 2023 relating to the Programme for the €75,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and irrevocably guaranteed as to payments by RBC Covered Bond Guarantor Limited Partnership.

Publication of a Prospectus

Regulatory Announcement Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Authority and is available for viewing: 4[th] Supplementary Notes Base Prospectus dated May 26, 2023 relating to the Programme for the Issuance of Securities of Royal Bank of Canada. The 4[th] Supplementary Notes Base Prospectus, together with the document incorporated by reference therein, has been submitted to the National Storage Mechanism and will shortly be

Curasight to present at HC Andersen Capital and Økonomisk Ugebrev

Copenhagen, Denmark, 26 May 2023 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company’s Interim Report Q1 2023 at HC Andersen Capital and at Økonomisk Ugebrev, 31 May 2023.The presentation will include an update on the business progress made by the company during the first part of 2023 and look ahead at the coming news flow expected in rest of H1 2023. Management will give an overall update on the company’s pipeline based on the proprietary uPAR theranostics platform and focused

Fantastical fungi folk feature in fine art show

Staffordshire University is inviting art lovers onto campus for its annual Degree Show packed full of creative student work.The free exhibition  runs from Friday 2 June to Saturday 10 June and showcases the final year work of more than 300 students across Art, Design, Media and Performance courses. Inspired by industry briefs, personal stories and fantastical ideas, the diverse projects on show offer something for everyone. In the Fine Art gallery, guests will be greeted by a colony of mushroom creatures crafted by Kite Myers. The figures

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS26 May 2023 at 15:45NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Anders BergPosition: Member of the Board/Deputy member Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 32434/5/4 ____________________________________________Transaction date: 2023-05-26Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction details(1):

BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.   Bergen 26 May 2023: Reference is made to the stock exchange announcement by BerGenBio ASA (the "Company") on 22 May 2023 regarding approval by the Company's annual general meeting of a partially underwritten rights

There are no items matching the current filter
There are no more items matching the current filter
Back to top